ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 232 filers reported holding ARGENX SE in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,785,772 | -1.9% | 70,756 | -22.2% | 0.06% | +8.8% |
| Q2 2023 | $35,451,788 | +20.8% | 90,965 | +15.5% | 0.06% | +16.3% |
| Q1 2023 | $29,335,830 | +5.4% | 78,737 | +7.1% | 0.05% | +2.1% |
| Q4 2022 | $27,844,383 | +13.8% | 73,501 | +6.1% | 0.05% | +11.6% |
| Q3 2022 | $24,464,000 | +117.5% | 69,297 | +133.4% | 0.04% | +126.3% |
| Q2 2022 | $11,247,000 | – | 29,686 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |